Product Name

  • Name

    Amphotericin B

  • EINECS 215-742-2
  • CAS No. 1397-89-3
  • Article Data9
  • CAS DataBase
  • Density 1.34 g/cm3
  • Solubility <0.1 g/100 mL at 21 °C in water
  • Melting Point >170 °C
  • Formula C47H73NO17
  • Boiling Point 1140.4 °C at 760 mmHg
  • Molecular Weight 924.093
  • Flash Point 643.5 °C
  • Transport Information UN 1759 8
  • Appearance crystalline yellow solid
  • Safety 26-36/37/39-45-36
  • Risk Codes 36/37/38
  • Molecular Structure Molecular Structure of 1397-89-3 (Amphotericin B)
  • Hazard Symbols IrritantXi
  • Synonyms Fungizone;Amphozone;component of Mysteclin-F;Mysteclin-F;33-((3-amino-3,6-dideoxyhexopyranosyl)oxy)-1,3,5,6,9,11,17,37-octahydroxy-15,16,18-trimethyl-13-oxo-14,39-dioxabicyclo[33.3.1]nonatriaconta-19,21,23,25,27,29,31-heptaene-36-carboxylic acid;Amphocin;IAB;Amphotericin B (JP14/USP);Amphotericin B (U.S. FDA Approved);AmphotericcinB;
  • PSA 319.61000
  • LogP 1.41200

Synthetic route

amphotericin B methyl ester
36148-89-7

amphotericin B methyl ester

AmBisome
1397-89-3

AmBisome

Conditions
ConditionsYield
With lithium hydroxide In tetrahydrofuran; water at 25℃; for 1h;80%
4-formylphenylcarbonyl-terminated poly(ethylene glycol)-poly[Nε-(4-formylphenyl-carbonyl)-L-lysine] amphotericin B Schiff's base, block copolymer, Mw = 26700, Mw/Mn = 1.11

4-formylphenylcarbonyl-terminated poly(ethylene glycol)-poly[Nε-(4-formylphenyl-carbonyl)-L-lysine] amphotericin B Schiff's base, block copolymer, Mw = 26700, Mw/Mn = 1.11

AmBisome
1397-89-3

AmBisome

Conditions
ConditionsYield
With water In phosphate buffer at 37℃; pH=5.5; Kinetics;
N-(4-carboxybenzylidene)amphotericin B

N-(4-carboxybenzylidene)amphotericin B

AmBisome
1397-89-3

AmBisome

Conditions
ConditionsYield
With phosphate buffer In methanol at 37℃; pH=5.5; Kinetics; Acid hydrolysis;
poly(ethylene glycol), Mw 10000 (of polyethylene glycol chain), conjugated with amphotericin B through O,O'-bis(1,4-C(O)C6H4-C=)-linker, in molar ratio 1:2

poly(ethylene glycol), Mw 10000 (of polyethylene glycol chain), conjugated with amphotericin B through O,O'-bis(1,4-C(O)C6H4-C=)-linker, in molar ratio 1:2

AmBisome
1397-89-3

AmBisome

Conditions
ConditionsYield
With phosphate buffer In methanol at 37℃; pH=5.5; Kinetics; Acid hydrolysis;
poly(ethylene glycol), Mw 20000 (of polyethylene glycol chain), conjugated with amphotericin B through O,O'-bis-(1,4-C(O)C6H4-C=)-linker, in molar ratio 1:2

poly(ethylene glycol), Mw 20000 (of polyethylene glycol chain), conjugated with amphotericin B through O,O'-bis-(1,4-C(O)C6H4-C=)-linker, in molar ratio 1:2

AmBisome
1397-89-3

AmBisome

Conditions
ConditionsYield
With phosphate buffer In methanol at 37℃; pH=5.5; Kinetics; Acid hydrolysis;
O-methylpoly(ethylene glycol), Mw 5000 (of polyethylene glycol chain), conjugated with amphotericin B through O'-(1,4-C6H4-CH=)-linker

O-methylpoly(ethylene glycol), Mw 5000 (of polyethylene glycol chain), conjugated with amphotericin B through O'-(1,4-C6H4-CH=)-linker

AmBisome
1397-89-3

AmBisome

Conditions
ConditionsYield
With phosphate buffer In methanol at 37℃; pH=5.5; Kinetics; Acid hydrolysis;
O-methylpoly(ethylene glycol), Mw 5000 (of polyethylene glycol chain), conjugated with amphotericin B through O'-(1,4-CH2CH2NHCOC6H4C=)-linker

O-methylpoly(ethylene glycol), Mw 5000 (of polyethylene glycol chain), conjugated with amphotericin B through O'-(1,4-CH2CH2NHCOC6H4C=)-linker

AmBisome
1397-89-3

AmBisome

Conditions
ConditionsYield
With phosphate buffer In methanol at 37℃; pH=5.5; Kinetics; Acid hydrolysis;
O-methylpoly(ethylene glycol), Mw 5000 (of polyethylene glycol chain), conjugated with amphotericin B through O'-(1,4-C(O)C6H4-C=)-linker

O-methylpoly(ethylene glycol), Mw 5000 (of polyethylene glycol chain), conjugated with amphotericin B through O'-(1,4-C(O)C6H4-C=)-linker

AmBisome
1397-89-3

AmBisome

Conditions
ConditionsYield
With phosphate buffer In methanol at 37℃; pH=5.5; Kinetics; Acid hydrolysis;
C55H85NO17

C55H85NO17

AmBisome
1397-89-3

AmBisome

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 1.) CSA; 2.) H2O / 1.) MeOH, 25 deg C, 2 h; 2.) MeOH, 25 deg C, 4 h
2: 80 percent / LiOH / tetrahydrofuran; H2O / 1 h / 25 °C
View Scheme
C55H83N3O17

C55H83N3O17

AmBisome
1397-89-3

AmBisome

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: 90 percent / HS(CH2)3SH, Et3N / methanol / 24 h / 25 °C
2: 1.) CSA; 2.) H2O / 1.) MeOH, 25 deg C, 2 h; 2.) MeOH, 25 deg C, 4 h
3: 80 percent / LiOH / tetrahydrofuran; H2O / 1 h / 25 °C
View Scheme
amphotericin B methyl pivalate
1112349-87-7

amphotericin B methyl pivalate

AmBisome
1397-89-3

AmBisome

Conditions
ConditionsYield
With water In dimethyl sulfoxide at 37℃; pH=7; Phosphate buffer; Enzymatic reaction;
N-(9H-fluoren-2-ylmethoxycarbonyloxy)succinimide
82911-69-1

N-(9H-fluoren-2-ylmethoxycarbonyloxy)succinimide

AmBisome
1397-89-3

AmBisome

3′-N-Fmoc-AmB
127970-81-4

3′-N-Fmoc-AmB

Conditions
ConditionsYield
With pyridine In N,N-dimethyl-formamide at 20℃; for 18h;100%
With pyridine In methanol; N,N-dimethyl-formamide at 23℃; for 4h;99%
With pyridine In methanol; N,N-dimethyl-formamide at 20℃; for 12h;95%
N-(allyloxycarbonyloxy)succinimide
135544-68-2

N-(allyloxycarbonyloxy)succinimide

AmBisome
1397-89-3

AmBisome

C51H77NO19

C51H77NO19

Conditions
ConditionsYield
With pyridine In methanol; N,N-dimethyl-formamide at 23℃; for 16h; Inert atmosphere;100%
In methanol; N,N-dimethyl-formamide at 23℃; for 16h;100%
With pyridine In methanol; N,N-dimethyl-formamide at 23℃; Inert atmosphere;99%
N-(allyloxycarbonyloxy)succinimide
135544-68-2

N-(allyloxycarbonyloxy)succinimide

AmBisome
1397-89-3

AmBisome

C50H75NO19

C50H75NO19

Conditions
ConditionsYield
With pyridine In methanol; N,N-dimethyl-formamide99%
AmBisome
1397-89-3

AmBisome

1H-pyrazole-1-carboximidamide hydrochloride
4023-02-3

1H-pyrazole-1-carboximidamide hydrochloride

guanidine-AmB
1033521-39-9

guanidine-AmB

Conditions
ConditionsYield
With N-ethyl-N,N-diisopropylamine In N,N-dimethyl-formamide at 20℃; for 16h; Inert atmosphere;97%
AmBisome
1397-89-3

AmBisome

amphotericin B

amphotericin B

Conditions
ConditionsYield
With benzotriazol-1-yloxyl-tris-(pyrrolidino)-phosphonium hexafluorophosphate; triethylamine In dimethyl sulfoxide at 23 - 25℃; for 24h; Reagent/catalyst; Solvent; Inert atmosphere; Darkness;97%
AmBisome
1397-89-3

AmBisome

benzylamine
100-46-9

benzylamine

amphotericin B N-benzylamide

amphotericin B N-benzylamide

Conditions
ConditionsYield
With diphenyl phosphoryl azide; triethylamine In N,N-dimethyl acetamide at 20℃;95.5%
With triethylamine In N,N-dimethyl acetamide at 20℃; Inert atmosphere;
3-Aminomethylpyridine
3731-52-0

3-Aminomethylpyridine

AmBisome
1397-89-3

AmBisome

amphotericin B 3-pyridylamide

amphotericin B 3-pyridylamide

Conditions
ConditionsYield
With diphenyl phosphoryl azide; triethylamine In N,N-dimethyl acetamide at 20℃; Darkness; Inert atmosphere;95.09%
N-cyclohexylmaleimide
1631-25-0

N-cyclohexylmaleimide

AmBisome
1397-89-3

AmBisome

N-(N-cyclohexylsuccinimidyl)-amphotericin B

N-(N-cyclohexylsuccinimidyl)-amphotericin B

Conditions
ConditionsYield
Michael Addition;94.6%
AmBisome
1397-89-3

AmBisome

amphotericin B N-(D)-methoxytryptophanamide

amphotericin B N-(D)-methoxytryptophanamide

Conditions
ConditionsYield
With diphenyl phosphoryl azide; triethylamine In N,N-dimethyl acetamide at 20℃;93.85%
O-tert-Butyl-D-serine
18783-53-4

O-tert-Butyl-D-serine

AmBisome
1397-89-3

AmBisome

N-(O-tert-butyl-D-seryl)amphotericin B

N-(O-tert-butyl-D-seryl)amphotericin B

Conditions
ConditionsYield
With dicyclohexyl-carbodiimide93.3%
N-(2,6-dimethylphenyl)maleimide
1206-49-1

N-(2,6-dimethylphenyl)maleimide

AmBisome
1397-89-3

AmBisome

N-(N-2,6-dimethylphenylsuccinimidyl)-amphotericin B

N-(N-2,6-dimethylphenylsuccinimidyl)-amphotericin B

Conditions
ConditionsYield
Michael Addition;92.2%
O,O'-bis(4-formylphenylcarbonyl)poly(ethylene)glycol, Mw 20000 (of polyethylene glycol chain)

O,O'-bis(4-formylphenylcarbonyl)poly(ethylene)glycol, Mw 20000 (of polyethylene glycol chain)

AmBisome
1397-89-3

AmBisome

poly(ethylene glycol), Mw 20000 (of polyethylene glycol chain), conjugated with amphotericin B through O,O'-bis-(1,4-C(O)C6H4-C=)-linker, in molar ratio 1:2

poly(ethylene glycol), Mw 20000 (of polyethylene glycol chain), conjugated with amphotericin B through O,O'-bis-(1,4-C(O)C6H4-C=)-linker, in molar ratio 1:2

Conditions
ConditionsYield
With 4 A molecular sieve; trimethyl orthoformate In N,N-dimethyl-formamide at 20℃;92%
histamine
51-45-6

histamine

AmBisome
1397-89-3

AmBisome

amphotericin B N-histaminamide

amphotericin B N-histaminamide

Conditions
ConditionsYield
With diphenyl phosphoryl azide; triethylamine In N,N-dimethyl acetamide at 20℃; for 12h; Inert atmosphere; Darkness;92%
AmBisome
1397-89-3

AmBisome

1-(2-tert-butylphenyl)-1H-pyrrole-2,5-dione
156775-78-9

1-(2-tert-butylphenyl)-1H-pyrrole-2,5-dione

N-(N-2-tert-butylphenylsuccinimidyl)-amphotericin B
1513872-40-6

N-(N-2-tert-butylphenylsuccinimidyl)-amphotericin B

Conditions
ConditionsYield
Michael Addition;91.9%
2-(methylamino)isobutyric acid
2566-34-9

2-(methylamino)isobutyric acid

AmBisome
1397-89-3

AmBisome

N-(N-methyl-α-methylalanyl)amphotericin B

N-(N-methyl-α-methylalanyl)amphotericin B

Conditions
ConditionsYield
With dicyclohexyl-carbodiimide91.1%
1-(2,4,6-trimethylphenyl)pyrrole-2,5-dione
55862-98-1

1-(2,4,6-trimethylphenyl)pyrrole-2,5-dione

AmBisome
1397-89-3

AmBisome

N-(N-2,4,6-trimethylphenylsuccinimidyl)-amphotericin B
1513872-37-1

N-(N-2,4,6-trimethylphenylsuccinimidyl)-amphotericin B

Conditions
ConditionsYield
Michael Addition;89.9%
Stage #1: AmBisome With triethylamine In N,N-dimethyl-formamide at 0℃; for 0.166667h;
Stage #2: 1-(2,4,6-trimethylphenyl)pyrrole-2,5-dione In N,N-dimethyl-formamide at 20℃;
30 mg
Fmoc-Glu(OtBu)-OH

Fmoc-Glu(OtBu)-OH

AmBisome
1397-89-3

AmBisome

N-(N-methyl-Oγ-tert-butyl-L-glutamyl)amphotericin B
1513872-70-2

N-(N-methyl-Oγ-tert-butyl-L-glutamyl)amphotericin B

Conditions
ConditionsYield
With dicyclohexyl-carbodiimide89.9%
AmBisome
1397-89-3

AmBisome

1-[(pyridin-4-yl)methyl]pyrrole-2,5-dione
46277-44-5

1-[(pyridin-4-yl)methyl]pyrrole-2,5-dione

N-{N-[(2-pyridin-4-yl)-methyl]succinimidyl}-amphotericin B

N-{N-[(2-pyridin-4-yl)-methyl]succinimidyl}-amphotericin B

Conditions
ConditionsYield
Michael Addition;89.7%
AmBisome
1397-89-3

AmBisome

(2R)-2-amino-4-tert-butoxy-4-oxobutanoic acid
64960-75-4

(2R)-2-amino-4-tert-butoxy-4-oxobutanoic acid

N-(Oβ-tert-butyl-D-aspartyl)amphotericin B
1513872-71-3

N-(Oβ-tert-butyl-D-aspartyl)amphotericin B

Conditions
ConditionsYield
With dicyclohexyl-carbodiimide88.4%
1-benzyl-1H-pyrrole-2,5-dione
1631-26-1

1-benzyl-1H-pyrrole-2,5-dione

AmBisome
1397-89-3

AmBisome

N-(N-benzylsuccinimidyl)-amphotericin B
1513872-38-2

N-(N-benzylsuccinimidyl)-amphotericin B

Conditions
ConditionsYield
Michael Addition;88%
1-piperidinepropionic acid
26371-07-3

1-piperidinepropionic acid

AmBisome
1397-89-3

AmBisome

N-[(3-piperidin-1-yl)propionyl]amphotericin B

N-[(3-piperidin-1-yl)propionyl]amphotericin B

Conditions
ConditionsYield
With dicyclohexyl-carbodiimide87.9%
(R)-2'-fluorophenylalanine
97731-02-7

(R)-2'-fluorophenylalanine

AmBisome
1397-89-3

AmBisome

N-(2-fluoro-D-phenylalanyl)amphotericin B

N-(2-fluoro-D-phenylalanyl)amphotericin B

Conditions
ConditionsYield
With dicyclohexyl-carbodiimide87.6%
(R)-phenylglycine
875-74-1

(R)-phenylglycine

AmBisome
1397-89-3

AmBisome

N-D-phenylglycyl-amphotericin B

N-D-phenylglycyl-amphotericin B

Conditions
ConditionsYield
With dicyclohexyl-carbodiimide87%
4-formylphenylcarbonyl-terminated poly(ethylene glycol)-poly[Nε-(4-formylphenyl-carbonyl)-L-lysine], block copolymer, Mw = 15500, Mw/Mn = 1.18

4-formylphenylcarbonyl-terminated poly(ethylene glycol)-poly[Nε-(4-formylphenyl-carbonyl)-L-lysine], block copolymer, Mw = 15500, Mw/Mn = 1.18

AmBisome
1397-89-3

AmBisome

4-formylphenylcarbonyl-terminated poly(ethylene glycol)-poly[Nε-(4-formylphenyl-carbonyl)-L-lysine] amphotericin B Schiff's base, block copolymer, Mw = 26700, Mw/Mn = 1.11

4-formylphenylcarbonyl-terminated poly(ethylene glycol)-poly[Nε-(4-formylphenyl-carbonyl)-L-lysine] amphotericin B Schiff's base, block copolymer, Mw = 26700, Mw/Mn = 1.11

Conditions
ConditionsYield
With 4 A molecular sieve; trimethyl orthoformate86%
O-methyl-O'-(4-formylphenylcarbonyl)poly(ethylene)glycol, Mw 5000 (of polyethylene glycol chain)

O-methyl-O'-(4-formylphenylcarbonyl)poly(ethylene)glycol, Mw 5000 (of polyethylene glycol chain)

AmBisome
1397-89-3

AmBisome

O-methylpoly(ethylene glycol), Mw 5000 (of polyethylene glycol chain), conjugated with amphotericin B through O'-(1,4-C(O)C6H4-C=)-linker

O-methylpoly(ethylene glycol), Mw 5000 (of polyethylene glycol chain), conjugated with amphotericin B through O'-(1,4-C(O)C6H4-C=)-linker

Conditions
ConditionsYield
With 4 A molecular sieve; trimethyl orthoformate In N,N-dimethyl-formamide at 20℃;86%
1-[3-(N,N-dimethylamino)-2,2-dimethylpropyl]-pyrrole-2,5-dione
1021027-70-2

1-[3-(N,N-dimethylamino)-2,2-dimethylpropyl]-pyrrole-2,5-dione

AmBisome
1397-89-3

AmBisome

N-{N-[3-(N,N-dimethylamino)-2,2-dimethylpropyl]-succinimidyl}-amphotericin B
1513872-43-9

N-{N-[3-(N,N-dimethylamino)-2,2-dimethylpropyl]-succinimidyl}-amphotericin B

Conditions
ConditionsYield
Michael Addition;85.5%
2-methyl-3-(pyridin-3-yl)propanoic acid

2-methyl-3-(pyridin-3-yl)propanoic acid

AmBisome
1397-89-3

AmBisome

N-[β-(pyridine-1-yl)-D-alanyl]amphotericin B
1513872-72-4

N-[β-(pyridine-1-yl)-D-alanyl]amphotericin B

Conditions
ConditionsYield
With dicyclohexyl-carbodiimide85.3%
AmBisome
1397-89-3

AmBisome

6-(9H-fluoren-9-ylmethoxycarbonylamino)hexanoic acid 2,5-dioxopyrrolidin-1-yl ester
125697-63-4

6-(9H-fluoren-9-ylmethoxycarbonylamino)hexanoic acid 2,5-dioxopyrrolidin-1-yl ester

N-(Fmoc-6-aminohexanoyl)-amphotericin B
942412-22-8

N-(Fmoc-6-aminohexanoyl)-amphotericin B

Conditions
ConditionsYield
With pyridine In N,N-dimethyl-formamide for 20h;85%
AmBisome
1397-89-3

AmBisome

4-Carboxybenzaldehyde
619-66-9

4-Carboxybenzaldehyde

N-(4-carboxybenzylidene)amphotericin B

N-(4-carboxybenzylidene)amphotericin B

Conditions
ConditionsYield
With 4 A molecular sieve; trimethyl orthoformate In dimethyl sulfoxide at 25℃; for 48h;84%
O,O'-bis(4-formylphenylcarbonyl)poly(ethylene)glycol, Mw 10000 (of polyethylene glycol chain)

O,O'-bis(4-formylphenylcarbonyl)poly(ethylene)glycol, Mw 10000 (of polyethylene glycol chain)

AmBisome
1397-89-3

AmBisome

poly(ethylene glycol), Mw 10000 (of polyethylene glycol chain), conjugated with amphotericin B through O,O'-bis(1,4-C(O)C6H4-C=)-linker, in molar ratio 1:2

poly(ethylene glycol), Mw 10000 (of polyethylene glycol chain), conjugated with amphotericin B through O,O'-bis(1,4-C(O)C6H4-C=)-linker, in molar ratio 1:2

Conditions
ConditionsYield
With 4 A molecular sieve; trimethyl orthoformate In N,N-dimethyl-formamide at 20℃;83%

Amphotericin B Specification

The Amphotericin B, with the CAS registry number 1397-89-3,is also known as 33-[(3-Amino-3,6-dideoxy-beta-D-mannopyranosyl)oxy]-1,3,5,6,9,11,17,37-octahydroxy-15,16,18-trimethyl-13-oxo-14,39-Dioxabicyclo[33.3.1]nonatriaconta-19,21,23,25,27,29,31-heptaene-36-carboxylic acid; Fungizone. It belongs to the product categories of Antifungal;Carbohydrates & Derivatives;Chiral Reagents. This chemical's molecular formula is C47H73NO17 and molecular weight is 924.08.Its EINECS number is 215-742-2. What's more,Its systematic name is Amphotericin B.It is a Crystalline Yellow Solid which is stable,incompatible with strong oxidizing agents,but may be light sensitive. It is a kind of polyene antifungal drugs,Isolated from Streptomyces culture.

Physical properties about Amphotericin B are:
(1)ACD/LogP:  1.164; (2)# of Rule of 5 Violations:  3; (3)ACD/LogD (pH 5.5):  -1.34; (4)ACD/LogD (pH 7.4):  -1.41; (5)ACD/BCF (pH 5.5):  1.00; (6)ACD/BCF (pH 7.4):  1.00; (7)ACD/KOC (pH 5.5):  1.00; (8)ACD/KOC (pH 7.4):  1.00; (9)#H bond acceptors:  18; (10)#H bond donors:  13; (11)#Freely Rotating Bonds:  14; (12)Index of Refraction:  1.614; (13)Molar Refractivity:  240.249 cm3; (14)Molar Volume:  689.435 cm3; (15)Surface Tension:  71.6880035400391 dyne/cm; (16)Density:  1.34 g/cm3; (17)Flash Point:  643.47 °C; (18)Enthalpy of Vaporization:  189.982 kJ/mol; (19)Boiling Point:  1140.365 °C at 760 mmHg; (20)Vapour Pressure:  0 mmHg at 25°C.

You can still convert the following datas into molecular structure:
(1)SMILES:C[C@H]1/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@@H](C[C@H]2[C@@H]([C@H](C[C@](O2)(C[C@H](C[C@H]([C@@H](CC[C@H](C[C@H](CC(=O)O[C@H]([C@@H]([C@@H]1O)C)C)O)O)O)O)O)O)O)C(=O)O)O[C@H]3[C@H]([C@H]([C@@H]([C@H](O3)C)O)N)O;
(2)Std. InChI:InChI=1S/C47H73NO17/c1-27-17-15-13-11-9-7-5-6-8-10-12-14-16-18-34(64-46-44(58)41(48)43(57)30(4)63-46)24-38-40(45(59)60)37(54)26-47(61,65-38)25-33(51)22-36(53)35(52)20-19-31(49)21-32(50)23-39(55)62-29(3)28(2)42(27)56/h5-18,27-38,40-44,46,49-54,56-58,61H,19-26,48H2,1-4H3,(H,59,60)/b6-5+,9-7+,10-8+,13-11+,14-12+,17-15+,18-16+/t27-,28-,29-,30+,31+,32+,33-,34-,35+,36+,37-,38-,40+,41-,42+,43+,44-,46-,47+/m0/s1;
(3)Std. InChIKey:APKFDSVGJQXUKY-INPOYWNPSA-N.

Safety Information of Amphotericin B:
The Amphotericin B is irritating to eyes, respiratory system and skin and harmful if swallowed.But there is limited evidence of a carcinogenic effect.It is toxic by inhalation, in contact with skin. In case of contact with eyes, rinse immediately with plenty of water and seek medical advice. When you use it ,wear suitable protective clothing, gloves and eye/face protection. In case of accident or if you feel unwell, seek medical advice immediately (show the label whenever possible.) .

The toxicity data of Amphotericin B as follows:

Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
dog LD50 intravenous 6mg/kg (6mg/kg) KIDNEY, URETER, AND BLADDER: OTHER CHANGES Biokhimiya Vol. 43, Pg. 2043, 1978.
infant TDLo intravenous 15mg/kg/4D-I (15mg/kg)   Journal of Toxicology, Clinical Toxicology. Vol. 28, Pg. 371, 1990.
infant TDLo intravenous 15mg/kg/4D-I (15mg/kg)   Journal of Toxicology, Clinical Toxicology. Vol. 28, Pg. 371, 1990.
man LDLo intravenous 164ug/kg/5H-I (0.164mg/kg) CARDIAC: OTHER CHANGES Drug Intelligence and Clinical Pharmacy. Vol. 17, Pg. 547, 1983.
mouse LD unreported > 50mg/kg (50mg/kg)   Journal of Antibiotics. Vol. 24, Pg. 561, 1971.
mouse LD12 oral 280mg/kg (280mg/kg)   British UK Patent Application. Vol. #2067993,
mouse LD50 intramuscular > 5gm/kg (5000mg/kg)   Iyakuhin Kenkyu. Study of Medical Supplies. Vol. 7, Pg. 108, 1976.
mouse LD50 intraperitoneal 27740ug/kg (27.74mg/kg)   National Cancer Institute Screening Program Data Summary, Developmental Therapeutics Program. Vol. JAN1986,
mouse LD50 intravenous 1200ug/kg (1.2mg/kg)   Pharmacy International. Vol. 6, Pg. 164, 1985.
rabbit LDLo intravenous 5mg/kg (5mg/kg) BEHAVIORAL: TREMOR

BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD
Antibiotics Annual. Vol. 5, Pg. 53, 1957/1958.
rat LD50 intramuscular > 5gm/kg (5000mg/kg)   Iyakuhin Kenkyu. Study of Medical Supplies. Vol. 7, Pg. 108, 1976.
rat LD50 intraperitoneal > 5gm/kg (5000mg/kg)   Iyakuhin Kenkyu. Study of Medical Supplies. Vol. 7, Pg. 108, 1976.
rat LD50 intravenous 1600ug/kg (1.6mg/kg)   Journal of Antimicrobial Chemotherapy. Vol. 28(Suppl,
rat LD50 oral > 5gm/kg (5000mg/kg)   Iyakuhin Kenkyu. Study of Medical Supplies. Vol. 7, Pg. 108, 1976.
women LDLo intravenous 22mg/kg/4D-I (22mg/kg) BLOOD: LEUKOPENIA Southern Medical Journal. Vol. 76, Pg. 409, 1983.
women TDLo intravenous 20ug/kg (0.02mg/kg) LUNGS, THORAX, OR RESPIRATION: OTHER CHANGES New England Journal of Medicine. Vol. 315, Pg. 836, 1986.
women TDLo intravenous 1mg/kg/1H-C (1mg/kg) CARDIAC: PULSE RATE Lancet. Vol. 341, Pg. 372, 1993.

Post buying leads

About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia

Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog

©2008 LookChem.com,License: ICP

NO.:Zhejiang16009103

complaints:service@lookchem.com Desktop View